Atherosclerosis
Volume 205, Issue 2 , Pages 632-636 , August 2009

Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population

  • Stamatis P. Efstathiou

      Affiliations

    • Center for Cardiovascular Disease Prevention, ‘Hygeias Melathron’, Athens, Greece
    • Corresponding Author InformationCorresponding author at: 19 Fidiou Street, Athens 15562, Greece. Tel.: +30 210 6534723; fax: +30 210 3349220.
  • ,
  • Irini I. Skeva

      Affiliations

    • Center for Cardiovascular Disease Prevention, ‘Hygeias Melathron’, Athens, Greece
  • ,
  • Cleanthi Dimas

      Affiliations

    • Biochemistry Department, ‘Attikon’ University Hospital, Athens, Greece
  • ,
  • Anna Panagiotou

      Affiliations

    • Biochemistry Department, ‘Attikon’ University Hospital, Athens, Greece
  • ,
  • Kleo Parisi

      Affiliations

    • Biochemistry Department, ‘Attikon’ University Hospital, Athens, Greece
  • ,
  • Labros Tzanoumis

      Affiliations

    • Center for Cardiovascular Disease Prevention, ‘Hygeias Melathron’, Athens, Greece
  • ,
  • Anna Kafouri

      Affiliations

    • Center for Cardiovascular Disease Prevention, ‘Hygeias Melathron’, Athens, Greece
  • ,
  • Konstantinos Bakratsas

      Affiliations

    • Center for Cardiovascular Disease Prevention, ‘Hygeias Melathron’, Athens, Greece
  • ,
  • Theodore D. Mountokalakis

      Affiliations

    • Center for Cardiovascular Disease Prevention, ‘Hygeias Melathron’, Athens, Greece

Received 20 November 2008 ,Revised 31 December 2008 ,Accepted 16 January 2009.

References 

  1. Bełtowski J, Jamroz-Wiśniewska A, Widomska S. Adiponectin and its role in cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets. 2008;8:7–46
  2. Thamer C, Stefan N, Stumvoll M, Häring H, Fritsche A. Reduced adiponectin serum levels in smokers. Atherosclerosis. 2005;179:421–422
  3. Iwashima Y, Katsuya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005;45:1094–1100
  4. Tsukinoki R, Morimoto K, Nakayama K. Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis. 2005;4:27
  5. Abbasi F, Farin HM, Lamendola C, et al. The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J Clin Endocrinol Metab. 2006;91:5002–5007
  6. Takefuji S, Yatsuya H, Tamakoshi K, et al. Smoking status and adiponectin in healthy Japanese men and women. Prev Med. 2007;45:471–475
  7. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen AA, Al Sharafi A, Abdella N. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Ann Nutr Metab. 2008;52:329–334
  8. Sull JW, Kim HJ, Yun JE, Park EJ, Kim G, Jee SH. Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J. 2009;56:73–78
  9. Miyazaki T, Shimada K, Mokuno H, Daida H. Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart. 2003;89:663
  10. Kim OY, Koh SJ, Jang Y, et al. Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clin Chim Acta. 2006;370:63–71
  11. Patel JV, Abraheem A, Dotsenko O, et al. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Intern Med. 2008;264:593–598
  12. West R. Bupropion SR for smoking cessation. Expert Opin Pharmacother. 2003;4:533–540
  13. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med. 1989;12:159–182
  14. Brinkman GL, Coates O. The effect of bronchitis, smoking and occupation on ventilation. Ann Rev Respir Dis. 1963;87:68–93
  15. Society for Research on Nicotine Tobacco (SRNT) Subcommittee on Biochemical Verification . Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4:149–159
  16. Isobe T, Saitoh S, Takagi S, et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol. 2005;153:91–98
  17. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–469
  18. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128–1130
  19. Ahonen TM, Kautiainen HJ, Keinänen-Kiukaanniemi SM, Kumpusalo EA, Vanhala MJ. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med. 2008;35:598–601
  20. Ellis JA, Perl SB, Davis K, Vichinsky L. Gender differences in smoking and cessation behaviors among young adults after implementation of local comprehensive tobacco control. Am J Public Health. 2008;98:310–316
  21. Andersson K, Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes Relat Metab Disord. 2001;25:1225–1232
  22. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001;507:142–146
  23. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32:47–50
  24. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204
  25. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17:2167–2176

PII: S0021-9150(09)00067-7

doi: 10.1016/j.atherosclerosis.2009.01.022

Atherosclerosis
Volume 205, Issue 2 , Pages 632-636 , August 2009